Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows a minor version update, Revision: v3.3.2, replacing v3.3.1, with no changes to study details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:19:54.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision metadata was updated: v3.3.1 added and v3.2.0 removed; no core study content, eligibility criteria, or outcomes appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:43:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The site-wide notice about government funding status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:22:30.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page based on the provided context.
    Difference
    0.4%
    Check dated 2025-11-03T00:51:25.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Summary: The page now displays an updated operating-status notice for NIH Clinical Center and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T08:31:04.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Update: page version bumped from v3.0.2 to v3.1.0; no other substantive content changes shown.
    Difference
    0.2%
    Check dated 2025-09-28T03:02:31.000Z thumbnail image

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.